AbbVie is entering a new phase of expansion as newer medicines offset the long decline in Humira sales and add momentum across key therapy areas. The company’s immunology and neuroscience ...
Abbott Laboratories is moving to separate its nutrition business into a standalone public company as the division faces litigation and operational strain tied to the baby formula market. The unit ...
Demand linked to artificial intelligence infrastructure continues to support ABB's growth in electrification and automation markets. The Swiss engineering group says orders for data centre ...
Europe’s biggest industrial companies are channeling gains from the AI-driven data centre boom into sharply different acquisition and product strategies. Schneider Electric and Siemens are ...
Trading in UMS Integration Ltd shares on Bursa Malaysia was suspended throughout Tuesday's session after the company requested a temporary halt. The move comes as the high-precision engineering ...
A broader market rotation is lifting U.S. healthcare shares as investors look for sectors with stronger earnings prospects and lower valuation risk. The shift comes after years of underperformance ...
Foreign takeovers of London-listed companies are continuing as low valuations and international business exposure keep attracting overseas buyers. The trend is intensifying at a time when only ...
Foreign takeovers of London-listed companies continue to gather pace as overseas buyers target UK groups with lower valuations and international operations. In that backdrop, Swiss engineering ...
Heightened U.S. scrutiny of China's biotechnology sector is widening to pharmaceutical research, as House lawmakers investigate whether clinical trials by Merck and AbbVie in China create ethical ...